"10.1371_journal.pone.0083905","plos one","2013-12-26T00:00:00Z","Takeshi Harada; Shuji Ozaki; Asuka Oda; Daisuke Tsuji; Akishige Ikegame; Masami Iwasa; Kengo Udaka; Shiro Fujii; Shingen Nakamura; Hirokazu Miki; Kumiko Kagawa; Yoshiaki Kuroda; Shigeto Kawai; Kohji Itoh; Hisafumi Yamada-Okabe; Toshio Matsumoto; Masahiro Abe","Department of Medicine and Bioregulatory Sciences, Graduate School of Medical Sciences, University of Tokushima, Tokushima, Japan; Department of Hematology, Tokushima Prefectural Central Hospital, Tokushima, Japan; Department of Medicinal Biotechnology, Graduate School of Pharmaceutical Sciences, University of Tokushima, Tokushima, Japan; Division of Medical Technology, Tokushima University Hospital, Tokushima, Japan; Department of Hematology and Oncology, RIRBM, Hiroshima University, Hiroshima, Japan; Research Division, Forerunner Pharma Research Co. Ltd., Tokyo, Japan; Research Division, Chugai Pharmaceutical Co. Ltd., Kanagawa, Japan","Conceived and designed the experiments: TH SO MA TM. Performed the experiments: TH AO DT AI. Analyzed the data: TH DT SO MA KI TM. Contributed reagents/materials/analysis tools: TH SO AO MI KU SF SN HM KK YK SK HYO. Wrote the paper: TH SO MA.","Shigeto Kawai and Hisafumi Yamada-Okabe are affiliated to the Research Division, Forerunner Pharma Research Co. Ltd., Tokyo, Japan, and the Research Division, Chugai Pharmaceutical Co. Ltd., Kanagawa, Japan, respectively. AHM and YB-AHM are products developed in Chugai Pharmaceutical Co. Ltd. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.","2013","12","Takeshi Harada","TH",17,TRUE,4,4,6,3,TRUE,TRUE,FALSE,0,NA,FALSE
